These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

309 related items for PubMed ID: 26048625

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Diffuse idiopathic skeletal hyperostosis in psoriatic arthritis.
    Haddad A, Thavaneswaran A, Toloza S, Chandran V, Gladman DD.
    J Rheumatol; 2013 Aug; 40(8):1367-73. PubMed ID: 23772085
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Predictors of early minimal disease activity in patients with psoriatic arthritis treated with tumor necrosis factor-α blockers.
    Iervolino S, Di Minno MN, Peluso R, Lofrano M, Russolillo A, Di Minno G, Scarpa R.
    J Rheumatol; 2012 Mar; 39(3):568-73. PubMed ID: 22247361
    [Abstract] [Full Text] [Related]

  • 6. Prevalence and characteristics of diffuse idiopathic skeletal hyperostosis (DISH) in Italy.
    Ciaffi J, Borlandelli E, Visani G, Facchini G, Miceli M, Ruscitti P, Cipriani P, Giacomelli R, Ursini F.
    Radiol Med; 2022 Oct; 127(10):1159-1169. PubMed ID: 36057932
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Obesity and the prediction of minimal disease activity: a prospective study in psoriatic arthritis.
    di Minno MN, Peluso R, Iervolino S, Lupoli R, Russolillo A, Scarpa R, di Minno G.
    Arthritis Care Res (Hoboken); 2013 Jan; 65(1):141-7. PubMed ID: 22514189
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Hemostatic and fibrinolytic changes are related to inflammatory conditions in patients with psoriatic arthritis--effect of different treatments.
    Di Minno MN, Iervolino S, Peluso R, Di Minno A, Ambrosino P, Scarpa R, CaRRDs Study Group.
    J Rheumatol; 2014 Apr; 41(4):714-22. PubMed ID: 24532831
    [Abstract] [Full Text] [Related]

  • 11. Minimal Disease Activity and Remission in Psoriatic Arthritis Patients Treated with Anti-TNF-α Drugs.
    Perrotta FM, Marchesoni A, Lubrano E.
    J Rheumatol; 2016 Feb; 43(2):350-5. PubMed ID: 26669925
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The effectiveness of a biologic agent on axial manifestations of psoriatic arthritis. A twelve months observational study in a group of patients treated with etanercept.
    Lubrano E, Spadaro A, Marchesoni A, Olivieri I, Scarpa R, D'Angelo S, Salvarani C, Mathieu A, Cauli A, Ferrara N, Helliwell P.
    Clin Exp Rheumatol; 2011 Feb; 29(1):80-4. PubMed ID: 21345296
    [Abstract] [Full Text] [Related]

  • 16. High prevalence of diffuse idiopathic skeletal hyperostosis (DISH) among obese young patients - A retrospective observational study.
    Brikman S, Lubani Y, Mader R, Bieber A.
    Semin Arthritis Rheum; 2024 Apr; 65():152356. PubMed ID: 38181545
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.